Q32 Bio Inc. Quarterly Income Tax Expense (Benefit) in USD from Q1 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Q32 Bio Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2021 to Q2 2024.
  • Q32 Bio Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $0.000.
  • Q32 Bio Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $0.000.
  • Q32 Bio Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000, a 100% decline from 2022.
  • Q32 Bio Inc. annual Income Tax Expense (Benefit) for 2022 was $715K.
  • Q32 Bio Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $0 $0 $0 Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $0 $0 $0 Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $0 $0 +$403K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 -$403K $0 -$46K -100% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 -$357K $0 -$105K -100% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$252K $0 -$967K -100% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $715K -$403K -$403K Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 $1.12M $46K +$46K Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $1.07M $105K +$105K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $967K $967K +$967K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $0 $0 Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.